title: Targeted immunotherapies overtaking emerging oncology market value based growth.
authors.affiliation: Department of Pharmacology and Toxicology, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia.
authors.forename: Mihajlo B
authors.initials: MB
authors.lastname: Jakovljevic
mesh_terms: D000970:Antineoplastic Agents / Q000191:economics* / Q000600:supply & distribution / Q000627:therapeutic use*; D002017:Budgets; D003132:Commerce; D003363:Cost Control; D003362:Cost-Benefit Analysis; D016527:Drug Costs / Q000639:trends; D004345:Drug Industry / Q000191:economics; D005102:Health Expenditures / Q000639:trends; D006297:Health Services Accessibility / Q000191:economics; D006801:Humans; D007167:Immunotherapy / Q000191:economics* / Q000639:trends; D008495:Medical Oncology / Q000191:economics* / Q000639:trends; D058990:Molecular Targeted Therapy / Q000191:economics* / Q000639:trends; D009369:Neoplasms / Q000188:drug therapy* / Q000191:economics* / Q000401:mortality; D055771:Serbia; D013997:Time Factors
chemical_list: D000970:Antineoplastic Agents